0001950047-23-002100.txt : 20230703 0001950047-23-002100.hdr.sgml : 20230703 20230703143322 ACCESSION NUMBER: 0001950047-23-002100 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230703 DATE AS OF CHANGE: 20230703 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 231064822 BUSINESS ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6157247755 MAIL ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Foley Mark J CENTRAL INDEX KEY: 0001529196 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: ZELTIQ AESTHETICS INC. STREET 2: 4698 WILLOW ROAD SUITE 100 CITY: PLEASANTON STATE: CA ZIP: 94588 144 1 primary_doc.xml 144 0001529196 XXXXXXXX LIVE 0001479290 REVANCE THERAPEUTICS, INC. 001-36297 1222 Demonbreun Street, Suite 2000 Nashville TN 37203 (615) 724-7755 MARK FOLEY Officer Director Common E*TRADE FINANCIAL CORPORATION

3 EDISON DRIVE ALPHARETTA GA 30005

26279 655398.26 84040352 07/03/2023 NASD COMMON 10/05/2017 Open Market Purchase ISSUER N 12923 10/05/2017 Cash COMMON 10/23/2017 Open Market Purchase ISSUER N 13356 10/23/2017 Cash N MARK FOLEY

1222 Demonbreun Street, Suite 2000 Nashville TN 37203

Common 06/09/2023 31279 962254.64 MARK FOLEY

1222 Demonbreun Street, Suite 2000 Nashville TN 37203

common 05/15/2023 70447 2431586.00 07/03/2023 03/10/2023 /s/ Mark Joseph Foley